In:
Psychogeriatrics, Wiley, Vol. 13, No. 3 ( 2013-09), p. 180-181
Abstract:
Memantine is an N ‐methyl‐ D ‐aspartate glutamate receptor antagonist that may improve cognitive functions in patients with A lzheimer's disease. It is predominantly excreted unchanged via the kidneys, and patients with decreased creatinine clearance must be treated with lower doses of memantine. However, it is unclear whether memantine itself can lead to renal dysfunction and/or hyperkalaemia. We report a patient with renal impairment and hyperkalaemia possibly associated with memantine administration.
Type of Medium:
Online Resource
ISSN:
1346-3500
,
1479-8301
DOI:
10.1111/psyg.2013.13.issue-3
Language:
English
Publisher:
Wiley
Publication Date:
2013
detail.hit.zdb_id:
2110287-9
Permalink